84 related articles for article (PubMed ID: 17347483)
1. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
[TBL] [Abstract][Full Text] [Related]
2. Plant-based Food Cyanidin-3-Glucoside Modulates Human Platelet Glycoprotein VI Signaling and Inhibits Platelet Activation and Thrombus Formation.
Yao Y; Chen Y; Adili R; McKeown T; Chen P; Zhu G; Li D; Ling W; Ni H; Yang Y
J Nutr; 2017 Oct; 147(10):1917-1925. PubMed ID: 28855423
[No Abstract] [Full Text] [Related]
3. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
[TBL] [Abstract][Full Text] [Related]
5. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
6. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
[TBL] [Abstract][Full Text] [Related]
7. Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber.
Florian P; Wonerow P; Harder S; Kuczka K; Dubar M; Graff J
Eur J Clin Pharmacol; 2017 Aug; 73(8):949-956. PubMed ID: 28523478
[TBL] [Abstract][Full Text] [Related]
8. Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties.
Sauge E; Pechkovsky D; Atmuri NDP; Tehrani AY; White Z; Dong Y; Cait J; Hughes M; Tam A; Donen G; Yuen C; Walker MJA; McNagny KM; Sin DD; Ciufolini MA; Bernatchez P
Vascul Pharmacol; 2022 Dec; 147():107112. PubMed ID: 36179789
[TBL] [Abstract][Full Text] [Related]
9. Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation.
Jooss NJ; Smith CW; Slater A; Montague SJ; Di Y; O'Shea C; Thomas MR; Henskens YMC; Heemskerk JWM; Watson SP; Poulter NS
J Thromb Haemost; 2022 Nov; 20(11):2617-2631. PubMed ID: 35894121
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the GPVI inhibitors losartan and honokiol.
Onselaer MB; Nagy M; Pallini C; Pike JA; Perrella G; Quintanilla LG; Eble JA; Poulter NS; Heemskerk JWM; Watson SP
Platelets; 2020; 31(2):187-197. PubMed ID: 30849265
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein VI - novel target in antiplatelet medication.
Borst O; Gawaz M
Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
[TBL] [Abstract][Full Text] [Related]
12. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
[TBL] [Abstract][Full Text] [Related]
13. Reverse correlations of collagen-dependent platelet aggregation and adhesion with GPVI shedding during storage.
Hosseini E; Beshkar P; Ghasemzadeh M
J Thromb Thrombolysis; 2018 Nov; 46(4):534-540. PubMed ID: 30218271
[TBL] [Abstract][Full Text] [Related]
14. Ceramidase critically affects GPVI-dependent platelet activation and thrombus formation.
Münzer P; Mittelstädt S; Geue S; Manke MC; Walker-Allgaier B; Lang F; Gawaz M; Borst O
Biochem Biophys Res Commun; 2018 Feb; 496(3):792-798. PubMed ID: 29395079
[TBL] [Abstract][Full Text] [Related]
15. Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke.
Induruwa I; Jung SM; Warburton EA
Int J Stroke; 2016 Aug; 11(6):618-25. PubMed ID: 27312676
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein VI (GPVI)-functionalized nanoparticles targeting arterial injury sites under physiological flow.
Levi M; Epshtein M; Castor T; Gawaz M; Korin N
Nanomedicine; 2020 Oct; 29():102274. PubMed ID: 32712174
[TBL] [Abstract][Full Text] [Related]
17. Losartan and metabolite EXP3179 activate endothelial function without lowering blood pressure in AT2 receptor KO mice.
Sauge E; White Z; Lizotte F; Yuen C; Atmuri NDP; Ciufolini MA; Geraldes P; Bernatchez P
Eur J Pharmacol; 2024 May; 977():176663. PubMed ID: 38815786
[TBL] [Abstract][Full Text] [Related]
18. High-throughput elucidation of thrombus formation reveals sources of platelet function variability.
van Geffen JP; Brouns SLN; Batista J; McKinney H; Kempster C; Nagy M; Sivapalaratnam S; Baaten CCFMJ; Bourry N; Frontini M; Jurk K; Krause M; Pillitteri D; Swieringa F; Verdoold R; Cavill R; Kuijpers MJE; Ouwehand WH; Downes K; Heemskerk JWM
Haematologica; 2019 Jun; 104(6):1256-1267. PubMed ID: 30545925
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.
Miguel-Carrasco JL; Beaumont J; San José G; Moreno MU; López B; González A; Zalba G; Díez J; Fortuño A; Ravassa S
Sci Rep; 2017 Feb; 7():41865. PubMed ID: 28157237
[TBL] [Abstract][Full Text] [Related]
20. Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles.
Bhunia SS; Misra A; Khan IA; Gaur S; Jain M; Singh S; Saxena A; Hohlfield T; Dikshit M; Saxena AK
J Med Chem; 2017 Jan; 60(1):322-337. PubMed ID: 27996269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
